Coregistration of 18F-FDG-PET and MRI in the Staging of Potentially Resectable Hilar Cholangiocarcinoma: a Pilot Study

[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

NCT04252859 ·Status: TERMINATED ·Phase: PHASE2

18F-FCH (Fluorocholine)-PET/MR in Staging of High-Risk Prostate Cancer

NCT01993160 ·Status: COMPLETED ·Phase: NA

Combination PET With 18F-fluorodeoxyglucose (18F-FDG) and 18 F-choline in Patient With HCC

NCT04391348 ·Status: COMPLETED ·Phase: NA

Hypoxic Changes in Hepatocellular Carcinoma (HCC) Following Trans Arterial Chemo Embolization and Stereotactic Radiation: Fluorine18 (18F) Fluoromisonidazole (FMISO) Imaging

NCT03303469 ·Status: TERMINATED ·Phase: PHASE2

Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)

NCT01179360 ·Status: COMPLETED

Treatment Monitoring of Advanced Colorectal Cancer With 18F-FDG PET/CT

NCT00823810 ·Status: TERMINATED ·Phase: NA

Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer

NCT02751710 ·Status: COMPLETED ·Phase: NA

PET-MRI Esophagus Feasibility Study

NCT05796102 ·Status: RECRUITING ·Phase: NA

Multiparametric PET-MRI Integration for a New Approach to Tumor Heterogeneity in Non-Small Cell Lung Cancer (NSCLC): Pilot Study

NCT03606070 ·Status: TERMINATED ·Phase: NA

FAPI PET for Response Evaluation and Prognosis Prediction in Liver and Biliary Cancer Patients Treated With PD-1 Combination Therapy

NCT05662488 ·Status: UNKNOWN

Non-invasive Prediction of Microvascular Invasion in Hepatocellular Carcinoma by Blood-Oxygen-Level Dependent Magnetic Resonance Imaging (BOLD MRI)

NCT00963612 ·Status: COMPLETED ·Phase: NA

PET/MR in Radiotherapy for Head and Neck Cancer Pilot

NCT02952625 ·Status: COMPLETED ·Phase: NA

Rectal Cancer: Local Staging, Re-staging and Assessment of Lymph Nodes Using Pet-Ct, CT-Perfusion and 3T MRI

NCT01525056 ·Status: COMPLETED ·Phase: PHASE2

Use of PET-MR in Head and Neck Cancer Patients - Diagnostic and Therapeutic Applications

NCT06032663 ·Status: RECRUITING ·Phase: NA

PET and MRI Imaging of Brain Tumors Using [18F]PARPi

NCT04173104 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Pilot Study to Evaluate 18F-fluorodeoxyglucose (FDG) Positron Emission Tomography /Computed Tomography (PET/CT) in Prediction of Early Response to Chemotherapy in Ovarian Cancer.

NCT00620243 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Follow-up of Patients With Curative-intent Surgical Resection for NSCLC

NCT00199615 ·Status: COMPLETED ·Phase: NA

Evaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms

NCT06791226 ·Status: RECRUITING ·Phase: NA

Comparison of PET/CT and Ultrasound in Staging of Malignant Melanoma

NCT04253574 ·Status: COMPLETED

18F-FDG PET/CT and Molecular Tumor Characterisation for Staging and Follow-up of Colon Cancer

NCT01636674 ·Status: UNKNOWN ·Phase: NA

Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors

NCT01075399 ·Status: COMPLETED ·Phase: PHASE2

Head and Neck Squamous Cell Carcinoma (HNSCC)PET-CT Pilot Study

NCT02678884 ·Status: RECRUITING ·Phase: NA

PET MRI as a Staging Tool for Head and Neck Cancer

NCT04750434 ·Status: COMPLETED

Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic Cancer

NCT03077334 ·Status: COMPLETED

Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection

NCT06206642 ·Status: COMPLETED ·Phase: NA